A network-based approach to integrate nutrient microenvironment in the prediction of synthetic lethality in cancer metabolism

被引:6
|
作者
Apaolaza, Inigo [1 ,2 ,3 ]
San Jose-Eneriz, Edurne [4 ,5 ,6 ]
Valcarcel, Luis V. [1 ,4 ,5 ]
Agirre, Xabier [4 ,5 ,6 ]
Prosper, Felipe [4 ,5 ,6 ,7 ]
Planes, Francisco J. [1 ,2 ,3 ]
机构
[1] Univ Navarra, Tecnun Escuela Ingn, San Sebastian, Spain
[2] Univ Navarra, Ctr Ingn Biomed, Pamplona, Spain
[3] Univ Navarra, DATAI Inst Ciencia Datos & Inteligencia Artificia, Pamplona, Spain
[4] Univ Navarra, CIMA Ctr Invest Med Aplicada, Pamplona, Spain
[5] IdiSNA Inst Invest Sanitaria Navarra, Pamplona, Spain
[6] CIBERONC Ctr Invest Biomed Red Canc, Pamplona, Spain
[7] Clin Univ Navarra, Pamplona, Spain
关键词
CELLS; REQUIREMENTS;
D O I
10.1371/journal.pcbi.1009395
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Synthetic Lethality (SL) is currently defined as a type of genetic interaction in which the loss of function of either of two genes individually has limited effect in cell viability but inactivation of both genes simultaneously leads to cell death. Given the profound genomic aberrations acquired by tumor cells, which can be systematically identified with -omics data, SL is a promising concept in cancer research. In particular, SL has received much attention in the area of cancer metabolism, due to the fact that relevant functional alterations concentrate on key metabolic pathways that promote cellular proliferation. With the extensive prior knowledge about human metabolic networks, a number of computational methods have been developed to predict SL in cancer metabolism, including the genetic Minimal Cut Sets (gMCSs) approach. A major challenge in the application of SL approaches to cancer metabolism is to systematically integrate tumor microenvironment, given that genetic interactions and nutritional availability are interconnected to support proliferation. Here, we propose a more general definition of SL for cancer metabolism that combines genetic and environmental interactions, namely loss of gene functions and absence of nutrients in the environment. We extend our gMCSs approach to determine this new family of metabolic synthetic lethal interactions. A computational and experimental proof-of-concept is presented for predicting the lethality of dihydrofolate reductase (DHFR) inhibition in different environments. Finally, our approach is applied to identify extracellular nutrient dependences of tumor cells, elucidating cholesterol and myo-inositol depletion as potential vulnerabilities in different malignancies. Author summary Metabolic reprogramming is one of the hallmarks of tumor cells. Synthetic lethality (SL) is a promising approach to exploit these metabolic alterations and elucidate cancer-specific genetic dependences. However, current SL approaches do not systematically consider tumor microenvironment, which is particularly important in cancer metabolism in order to generalize identified genetic dependences. In this article, we directly address this issue and propose a more general approach to SL that integrates both genetic and environmental context of tumor cells. Our definition can help to contextualize genetic dependencies in different environmental scenarios, but it could also reveal nutrient dependencies according to the genetic context. We also provide a computational pipeline to identify this new family of synthetic lethals in genome-scale metabolic networks. A computational and experimental proof-of-concept is presented for predicting the lethality of dihydrofolate reductase (DHFR) inhibition in different environments. Finally, our approach is applied to identify extracellular nutrient dependences of cancer cell lines, elucidating cholesterol and myo-Inositol depletion as potential vulnerabilities in different malignancies.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment
    Chan, Norman
    Pires, Isabel M.
    Bencokova, Zuzana
    Coackley, Carla
    Luoto, Kaisa R.
    Bhogal, Nirmal
    Lakshman, Minalini
    Gottipati, Ponnari
    Oliver, F. Javier
    Helleday, Thomas
    Hammond, Ester M.
    Bristow, Robert G.
    CANCER RESEARCH, 2010, 70 (20) : 8045 - 8054
  • [2] An in-silico approach to predict and exploit synthetic lethality in cancer metabolism
    Apaolaza, Inigo
    San Jose-Eneriz, Edurne
    Tobalina, Luis
    Miranda, Estibaliz
    Garate, Leire
    Agirre, Xabier
    Prosper, Felipe
    Planes, Francisco J.
    NATURE COMMUNICATIONS, 2017, 8
  • [3] An in-silico approach to predict and exploit synthetic lethality in cancer metabolism
    Iñigo Apaolaza
    Edurne San José-Eneriz
    Luis Tobalina
    Estíbaliz Miranda
    Leire Garate
    Xabier Agirre
    Felipe Prósper
    Francisco J. Planes
    Nature Communications, 8
  • [4] Graph based recurrent network for context specific synthetic lethality prediction
    Yuyang Jiang
    Jing Wang
    Yixin Zhang
    Zhi Wei Cao
    Qinglong Zhang
    Jinsong Su
    Song He
    Xiaochen Bo
    Science China(Life Sciences), 2025, 68 (02) : 527 - 540
  • [5] Graph based recurrent network for context specific synthetic lethality prediction
    Yuyang Jiang
    Jing Wang
    Yixin Zhang
    ZhiWei Cao
    Qinglong Zhang
    Jinsong Su
    Song He
    Xiaochen Bo
    Science China Life Sciences, 2025, 68 (2) : 527 - 540
  • [6] Identifying and targeting cancer-specific metabolism with network-based drug target prediction
    Pacheco, Maria Pires
    Bintener, Tamara
    Ternes, Dominik
    Kulms, Dagmar
    Haan, Serge
    Letellier, Elisabeth
    Sauter, Thomas
    EBIOMEDICINE, 2019, 43 : 98 - 106
  • [7] A network-based approach to enrich gene signatures for the prediction of breast cancer metastases
    Sfakianakis, Stelios
    Bei, Ekaterini S.
    Zervakis, Michalis
    Kafetzopoulos, Dimitrios
    2015 37TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2015, : 6497 - 6500
  • [8] Network-based prediction of human tissue-specific metabolism
    Tomer Shlomi
    Moran N Cabili
    Markus J Herrgård
    Bernhard Ø Palsson
    Eytan Ruppin
    Nature Biotechnology, 2008, 26 : 1003 - 1010
  • [9] Network-based prediction of human tissue-specific metabolism
    Shlomi, Tomer
    Cabili, Moran N.
    Herrgard, Markus J.
    Palsson, Bernhard O.
    Ruppin, Eytan
    NATURE BIOTECHNOLOGY, 2008, 26 (09) : 1003 - 1010
  • [10] A Study of Network-based Approach for Cancer Classification
    Jumali, R.
    Deris, S.
    Hashim, S. Z. M.
    Misman, M. F.
    Mohamad, M. S.
    2009 INTERNATIONAL CONFERENCE ON INFORMATION MANAGEMENT AND ENGINEERING, PROCEEDINGS, 2009, : 505 - 509